SCHEMBL7811486

SCHEMBL7811486

CC(C)OC(=O)C(C)(C)Oc1cccc(C2=CCN(C(=O)c3ccc(Cl)cc3)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.49
PPARA Q07869 4/20 0.49
CNR1 P21554 2/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
ABCB11 O95342 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
CYP2C9 P11712 1/20 0.49
ADRB3 P13945 1/20 0.49
TSHR P16473 1/20 0.49
ACHE P22303 1/20 0.49
SLC6A2 P23975 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804444 0.93 NAMPT (0.44) PPARGPPARACNR1LMNAMAPT
SCHEMBL7813905 0.92 ALDH1A1 (0.46) PPARGPPARALMNAMAPTHPGD
SCHEMBL7814015 0.91 NAMPT (0.44) PPARGPPARACNR1LMNAMAPT
SCHEMBL7809885 0.91 POLB (0.41) PPARGPPARACNR1LMNAMAPT
SCHEMBL7817528 0.91 NAMPT (0.49) PPARGPPARACNR1LMNAMAPT
SCHEMBL7817469 0.90 NAMPT (0.44) PPARGPPARACNR1LMNAMAPT
SCHEMBL7813624 0.90 POLB (0.40) PPARGPPARACNR1LMNAMAPT
SCHEMBL7811630 0.88 PPARA (0.60) PPARGPPARACNR1LMNAMAPT
SCHEMBL7804294 0.87 HPGD (0.39) PPARGPPARACNR1LMNAMAPT
SCHEMBL7813597 0.86 HPGD (0.39) PPARGPPARACNR1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed